Provided by Tiger Fintech (Singapore) Pte. Ltd.

Immunoprecise Antibodies Ltd

0.6724
-0.0296-4.22%
Post-market: 0.6700-0.0024-0.36%17:54 EDT
Volume:627.36K
Turnover:430.63K
Market Cap:30.77M
PE:-0.60
High:0.7289
Open:0.7286
Low:0.6600
Close:0.7020
Loading ...

ImmunoPrecise Antibodies Ltd. Unveils AI-Driven Universal Dengue Vaccine Discovery, Paving Way for Broader Infectious Disease Solutions

Reuters
·
05 Jun

Immunoprecise Announces AI-Driven Breakthrough in Universal Dengue Vaccine Discovery

THOMSON REUTERS
·
05 Jun

ImmunoPrecise Antibodies Ltd. Unveils Presentation on In Silico Strategies to Harness Rabbit-Derived Antibodies

Reuters
·
28 May

ImmunoPrecise Antibodies Partners with CORE IR to Boost Investor Engagement

Reuters
·
21 May

ImmunoPrecise Antibodies Ltd. to Present at Maxim Group's 2025 Virtual Tech Conference

Reuters
·
20 May

10 Barrel Brewing Launches Non-Alcoholic Apocalypse IPA, a Bold Craft Brew for Your Next Adventure

GlobeNewswire
·
30 Apr

Institutional Property Advisors Brokers Two Class A Office Tower Sale in Newport Beach, California

Business Wire
·
16 Apr

ImmunoPrecise Antibodies Price Target Maintained With a $5.00/Share by HC Wainwright & Co.

Dow Jones
·
12 Apr

ImmunoPrecise Antibodies Price Target Maintained With a $3.00/Share by Benchmark

Dow Jones
·
01 Apr

ImmunoPrecise Antibodies Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
31 Mar

ImmunoPrecise Antibodies price target lowered to $5 from $7 at H.C. Wainwright

TIPRANKS
·
31 Mar

ImmunoPrecise Antibodies Third Quarter 2025 Earnings: CA$0.66 loss per share (vs CA$0.11 loss in 3Q 2024)

Simply Wall St.
·
29 Mar

Immunoprecise Antibodies Ltd reports results for the quarter ended January 31 - Earnings Summary

Reuters
·
28 Mar

BRIEF-Immunoprecise Antibodies (IPA) Reports Financial Results And Recent Business Highlights For Third Quarter Fiscal Year 2025

Reuters
·
28 Mar

ImmunoPrecise Antibodies Q3 2025 GAAP EPS C$(0.66) May Not Be Comparable To C$(0.08) Estimate, Sales C$6.15M Miss C$6.58M Estimate

Benzinga
·
28 Mar

Immunoprecise Antibodies Q3 Revenue CAD 6.2 Million

THOMSON REUTERS
·
28 Mar

Immunoprecise Antibodies Ltd: Qtrly Shr Loss $0.66

THOMSON REUTERS
·
28 Mar

Immunoprecise Antibodies (Ipa) Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025

THOMSON REUTERS
·
28 Mar

Press Release: ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025

Dow Jones
·
28 Mar

SweetWater Brewing Company and Georgia Aquarium Celebrate Third Year of Partnership with Limited Edition Aquarium-Themed Can Art for OG IPA

GlobeNewswire
·
20 Mar